U.S. markets open in 5 hours 19 minutes

Meridian Mining S.E. (MNO.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.3700+0.0300 (+8.82%)
At close: 3:59PM EST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3400
Open0.3700
Bid0.3450 x 0
Ask0.3700 x 0
Day's Range0.3450 - 0.3750
52 Week Range0.0600 - 0.3900
Volume312,955
Avg. Volume271,505
Market Cap38.378M
Beta (5Y Monthly)1.36
PE Ratio (TTM)N/A
EPS (TTM)-0.1480
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Newsfile

      Meridian Announces Grant of Stock Options

      London, United Kingdom--(Newsfile Corp. - March 1, 2021) - Meridian Mining UK Societas (TSXV: MNO) ("Meridian" or the "Company") today announces that the board of directors of the Company has approved the grant of an aggregate of 3,335,000 options (the "Options") to purchase common shares in the capital of the Company to certain directors, officers, employees, consultants and advisors of the Company. The Options are exercisable at a price of $0.45 per common share ...

    • Biocytogen announces acquisition of a third Beacon Optofluidic system to support expanding Antibody Discovery Platform
      CNW Group

      Biocytogen announces acquisition of a third Beacon Optofluidic system to support expanding Antibody Discovery Platform

      25, 2021 /CNW/ -- Biocytogen, a company dedicated to accelerating therapeutic antibody discovery, has announced the acquisition of a third Beacon Optofluidic system. The new instrument, developed by Berkeley Lights, will support the expansion of Biocytogen's antibody discovery service platform in the greater Boston area for collaborations across the globe.

    • Meridian Announces Board Changes and New Directors
      Newsfile

      Meridian Announces Board Changes and New Directors

      London, United Kingdom--(Newsfile Corp. - January 26, 2021) - Meridian Mining UK Societas (TSXV: MNO) ("Meridian" or the "Company") today announces changes and expansion to its Board of Directors. To reflect the Company's focus towards the Cabaçal VMS Copper-Gold resource development and exploration project ("Cabaçal" or the "Project"), and with the completion of the Company's restructure and refinancing. Mr Gilbert Clark will take up effective today, the Executive Chairman's role of the Board while ...